
Q&A: Lykos just cut 75% of its workforce after an FDA rejection. Here’s what the CEO has to say
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Plus, news about Vericel: AN2 Therapeutics adopts poison pill: The small molecule drugmaker put forth the stockholder rights plan for a … Sign up to
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Esperion CMO JoAnne Foody has departed, the company disclosed in an Aug. 5 SEC filing. “We are grateful for her significant contributions to the company
The antibody-drug conjugate trastuzumab deruxtecan (T-DXd, Enhertu) proved active in a phase II study of advanced HER2-positive colorectal cancer (CRC). Almost 40% of patients treated
Two California doctors were among the five defendants charged in connection with the death of actor Matthew Perry, who died of a fatal ketamine overdose
One of the catchphrases of this election came from a moment 3 years ago when Donald Trump’s running mate JD Vance mocked Vice President Kamala
Herpes zoster was associated with an elevated risk of long-term subjective cognitive decline. The analysis followed 150,000 healthcare professionals in three cohorts for over a